Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Board Update

26 Feb 2009 07:00

RNS Number : 8965N
Genus PLC
26 February 2009
 



For immediate release 26 February 2009

Genus plc 

("Genus" or "the Company")

Board Update

Genus, a world leading animal genetics company, today announces that John Worby has been appointed as Finance Director of the Company with immediate effect. Mr Worby replaces Martin Boden who will be leaving the Company today to pursue other opportunities. John Worby joined the Board of the Company in September 2004 when he also became Chairman of the Audit Committee. Genus intends to strengthen the non executive representation on the Board by recruiting a replacement Audit Committee Chairman and enhancing the international commercial experience of the Board, particularly in emerging markets. A further announcement on this matter will be made in due course.

For further information please contact: Genus plc Tel: 01256 345 970 John Hawkins, Chairman

Buchanan Communications Tel: 020 7466 5000 Charles Ryland Isabel Podda Jennie Spivey About Genus Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality and use these to supply the global dairy and meat supply chain. The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network. Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADGGZZNKMGLZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.